PFE Operating Income Growth
Pfizer · Operating Income Growth
PFE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported31.64%period ending
PFE Quarterly Operating Income YoY % (14.84% → 31.64%)
Year-over-year change
High-resolution chart · PNG
PFE operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 31.6364% | |
| -12.8028% | |
| -35.5808% | |
| -28.5427% | |
| 90.2608% | |
| 1.4258% | |
| 553.2858% | |
| 265.2695% | |
| -20.0766% | |
| -31.8025% | |
| -123.6163% | |
| -130.9929% | |
| -81.8414% | |
| -33.4362% | |
| 63.0488% | |
| 25.1484% | |
| 116.2158% | |
| 108.7508% | |
| 256.1346% | |
| 210% | |
| 138.4707% | |
| 54.9936% | |
| -54.9413% | |
| -25.794% | |
| -40.257% | |
| -31.0069% | |
| -37.2043% | |
| -13.5267% | |
| 3.4457% | |
| 11.1413% | |
| 31.0386% | |
| 0.3865% | |
| 4.9058% | |
| -2.5048% | |
| -2.4735% | |
| 5.5767% | |
| 2.1091% | |
| 2.9762% | |
| 12.6493% | |
| -6.6768% | |
| 3.0427% | |
| 36.8171% | |
| -0.7027% | |
| 7.5348% | |
| -8.6827% | |
| 9.7988% | |
| -38.0914% | |
| -13.1373% | |
| -4.388% | |
| -36.5335% | |
| -0.8358% | |
| -0.8931% | |
| -21.0191% | |
| -12.0058% | |
| -13.3209% | |
| -16.2896% | |
| 20.009% | |
| 10.1031% | |
| 81.4673% | |
| 124.217% | |
| -13.3112% | |
| 10.2551% | |
| -31.1935% | |
| -47.5717% | |
| 43.324% | |
| -7.9302% | |
| -15.6742% | |
| 71.5192% | |
| 32.1521% | |
| 29.0904% | |
| 57.764% | |
| 203.3694% | |
| 24.0953% | |
| -29.8146% | |
| -0.8086% | |
| -78.5105% | |
| -37.7175% | |
| 6.3887% | |
| -28.6342% | |
| 3.6451% | |
| 3.5757% | |
| 7.0041% | |
| -22.492% | |
| -15.6646% | |
| -6.39% | |
| -18.4308% | |
| 68.0988% | |
| 69.7621% | |
| 91.1687% | |
| 46.2793% | |
| -15.9241% | |
| -18.5116% | |
| -26.677% | |
| 9.978% | |
| 20.2316% | |
| 12.6453% | |
| -0.2707% | |
| 13.9527% | |
| 20.2873% | |
| 24.0822% |